Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells

[1]  Marclippman.  The Effects of Estrogens and Antiestrogens on Hormone responsive Human Breast Cancer in Long-Term Tissue Culture , 2006 .

[2]  A. Wakeling.  The future of new pure antiestrogens in clinical breast cancer , 2004, Breast Cancer Research and Treatment.

[3]  R. Sutherland,et al.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Sutherland,et al.  Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes. , 1993, Biochemical and biophysical research communications.

[5]  J. A. Hamilton,et al.  Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.

[6]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[7]  A. Philips,et al.  Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. , 1993, The Journal of biological chemistry.

[8]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[9]  J. A. Hamilton,et al.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.

[10]  J. Pines,et al.  Cyclins and cyclin-dependent kinases: take your partners , 1993 .

[11]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[12]  K. Keyomarsi,et al.  Redundant cyclin overexpression and gene amplification in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Keyomarsi,et al.  Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. , 1992, The Journal of biological chemistry.

[14]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[15]  M. Parker,et al.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[17]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[18]  R. Sutherland,et al.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes , 1991, Molecular and cellular biology.

[19]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[20]  S. Reed,et al.  Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast , 1991, Cell.

[21]  P. Watson,et al.  Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. , 1991, Cancer research.

[22]  L. Murphy,et al.  Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[24]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[25]  B. O’Malley,et al.  Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[27]  R. Sutherland,et al.  Steroids, growth factors, and cell cycle controls in breast cancer. , 1991, Cancer treatment and research.

[28]  N. Davidson,et al.  Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. , 1991, Cancer research.

[29]  R. Daly,et al.  Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. , 1990, Cancer research.

[30]  V. Jordan,et al.  Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. , 1990, Cancer research.

[31]  C. Redmond,et al.  Endocrine treatment of breast cancer in women. , 1990, Endocrine reviews.

[32]  P. Nurse.  Universal control mechanism regulating onset of M-phase , 1990, Nature.

[33]  Y. Fujiwara,et al.  Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. , 1989, Cancer research.

[34]  J. Shine,et al.  Progestin Inhibition of Progesterone Receptor Gene Expression in Human these steroids is determined in part by the cellular Breast Cancer Cells , 1989 .

[35]  J. Abecassis,et al.  Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth. , 1989, Journal of medicinal chemistry.

[36]  A. Wakeling,et al.  Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. , 1989, Journal of molecular endocrinology.

[37]  R. Sutherland,et al.  Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. , 1989, Cancer research.

[38]  N. Brünner,et al.  Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. , 1989, Cancer research.

[39]  J. Shine,et al.  Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. , 1989, Molecular endocrinology.

[40]  A. Wakeling.  Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells. , 1989, Journal of steroid biochemistry.

[41]  V. Jordan,et al.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. , 1988, Cancer research.

[42]  C. Clarke,et al.  Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. , 1988, Cancer research.

[43]  J. T. Irwin,et al.  Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D. , 1988, Cancer research.

[44]  R. Nicholson,et al.  Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor. , 1988, Journal of steroid biochemistry.

[45]  R. Shiu,et al.  Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. , 1987, Cancer research.

[46]  B. Katzenellenbogen,et al.  Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. , 1987, Cancer research.

[47]  H. Rochefort,et al.  Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. , 1987, Biochemical and biophysical research communications.

[48]  A. Wakeling,et al.  Steroidal pure antioestrogens. , 1987, The Journal of endocrinology.

[49]  R. Sutherland,et al.  Substituted-vinyl hydroxytriarylethylenes, 1-[4-[2-(diethylamino) ethoxy]phenyl]-1-(4-hydroxyphenyl)-2-phenylethylenes: synthesis and effects on MCF 7 breast cancer cell proliferation. , 1986, Journal of Medicinal Chemistry.

[50]  V. Jordan.  Estrogen/Antiestrogen Action and Breast Cancer Therapy , 1986 .

[51]  R. Sutherland,et al.  Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor. , 1986, Biochemical and biophysical research communications.

[52]  L. Murphy,et al.  Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. , 1984, Cancer research.

[53]  C. Osborne,et al.  Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. , 1984, Cancer research.

[54]  L. Murphy,et al.  Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. , 1983, Cancer research.

[55]  I W Taylor,et al.  Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. , 1983, Cancer research.

[56]  I. Taylor,et al.  Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. , 1983, Cancer research.

[57]  I. Taylor,et al.  Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. , 1983, European journal of cancer & clinical oncology.

[58]  R. Sutherland,et al.  Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. , 1983, European journal of cancer & clinical oncology.

[59]  H. Rochefort,et al.  Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. , 1982, Cancer research.

[60]  I. Taylor.  A rapid single step staining technique for DNA analysis by flow microfluorimetry. , 1980, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[61]  C. Osborne,et al.  Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Lippman,et al.  Oestrogen-responsive human breast cancer in long term tissue culture , 1975, Nature.